Rapid7, Inc.

RPD
About the company

Rapid7, Inc. provides cybersecurity software and services under the Rapid7, Nexpose, and Metasploit brand names.

Country: United StatesPrice: $14.41Market Cap: $987.6M

Investment snapshot

12%positive consensus
Scored 1d ago

Positive

2

BUY / PASS

Neutral / negative

2 / 12

NEUTRAL / FAIL

Median fair value

$14.77

+2.5% vs price

Models with upside

3 / 17

Positive margin of safety

Strongest signal

8 of 10 pass — Lynch and Sleep object

Key risk

No clean pass — all 8 investors flag at least one efficiency criterion

Framework analysis

VerdictMeaning
BUYPositive purchase signal: the framework's buy requirements are met.
PASSThe company clears the framework's checklist or screen, but the framework does not produce a buy signal. For valuation frameworks this often means margin of safety is missing, insufficient, or unavailable; some screen-only frameworks have no intrinsic-value BUY state.
NEUTRALNeither a positive nor negative conclusion. It does not mean to hold an existing position.
FAILThe company does not clear the framework's requirements.
RankedRanked strategies do not use PASS: selected cohort is BUY, outside the cohort is FAIL, and unranked is NEUTRAL.

Current investor scores use trailing 12-month flows and the latest balance sheet where supported. Multi-year and EPS tests retain annual history; each framework shows its financial basis below. Intrinsic values use annual financials.

MetricGraham

Defensive Value

Buffett

Quality Compounder

Lynch

GARP

Greenblatt

Magic Formula

Piotroski

F-Score

Dreman

Contrarian Value

Munger

Quality Focus

Pabrai

Dhandho Framework

Akre

Three-Legged Stool

Marks

Risk-Aware Value

Ackman

Activist Value

Templeton

Global Bargain Hunter

Sleep

Scale Economies Shared

Asness

Systematic Factors

Neff

Low-P/E Total Return

Schloss

Asset-Value Discipline

O'Shaughnessy

Systematic Factor Composite

VerdictFAILFAILFAILNot rankedNEUTRALFAILFAILFAILFAILFAILPASSFAILPASSFAILFAILFAILNEUTRAL
Score
AnalysisChecking access…Checking access…Checking access…Checking access…Checking access…Checking access…Checking access…Checking access…Checking access…Checking access…Checking access…Checking access…Checking access…Checking access…Checking access…Checking access…Checking access…
Intrinsic Value (annual)N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Margin of Safety-229.7%-30.6%N/AN/AN/AN/A+64.5%+2.4%N/AN/A+70.8%N/AN/AN/AN/AN/AN/A
Financial Basis

TTM ended 2026-09-30 · Balance sheet at 2026-09-30 · Annual history · FY 2025

Latest source filing: 2026-11-04

Score computed: 2026-11-14

Annual history · FY 2025 · TTM ended 2026-09-30

Latest source filing: 2026-11-04

Score computed: 2026-11-14

Annual history · FY 2025 · Balance sheet at 2026-09-30 · TTM ended 2026-09-30 vs 2025-09-30 · TTM ended 2026-09-30

Latest source filing: 2026-11-04

Score computed: 2026-11-14

Annual history · FY 2025

Latest source filing: 2026-02-19

Score computed: 2026-11-14

Annual history · FY 2025

Latest source filing: 2026-02-19

Score computed: 2026-11-14

Annual history · FY 2025 · TTM ended 2026-09-30 · Balance sheet at 2026-09-30 · Market data at 2026-11-01

Latest source filing: 2026-11-04

Score computed: 2026-11-14

Qualitative assessment · Annual history · FY 2025 · TTM ended 2026-09-30 · Balance sheet at 2026-09-30

Latest source filing: 2026-11-04

Score computed: 2026-11-14

Qualitative assessment · Annual history · FY 2025

Latest source filing: 2026-02-19

Score computed: 2026-11-14

Annual history · FY 2025 · Qualitative assessment · TTM ended 2026-09-30 · Balance sheet at 2026-09-30

Latest source filing: 2026-11-04

Score computed: 2026-11-14

Annual history · FY 2025 · TTM ended 2026-09-30 · Qualitative assessment

Latest source filing: 2026-11-04

Score computed: 2026-11-14

Annual history · FY 2025 · TTM ended 2026-09-30 · Balance sheet at 2026-09-30 · Market data at 2026-11-01

Latest source filing: 2026-11-04

Score computed: 2026-11-14

Annual history · FY 2025 · Price history 2025-01-01–2026-11-01 · Balance sheet at 2026-09-30

Latest source filing: 2026-11-04

Score computed: 2026-11-14

Annual history · FY 2025 · Qualitative assessment

Latest source filing: 2026-02-19

Score computed: 2026-11-14

TTM ended 2026-09-30 · Balance sheet at 2026-09-30 · Price history 2025-01-01–2026-11-01 · Annual history · FY 2025

Latest source filing: 2026-11-04

Score computed: 2026-11-14

Annual history · FY 2025 · TTM ended 2026-09-30

Latest source filing: 2026-11-04

Score computed: 2026-11-14

Annual history · FY 2025 · Balance sheet at 2026-09-30

Latest source filing: 2026-11-04

Score computed: 2026-11-14

TTM ended 2026-09-30 · Annual history · FY 2025 · Price history 2025-01-01–2026-11-01

Latest source filing: 2026-11-04

Score computed: 2026-11-14

Where It Passes

  • Cash Flow80% pass✓ 10✗ 2▾

    8 of 10 pass — Lynch and Sleep object

    Free Cash Flow Proxy$61.2M
    ✓BuffettPositive and growing
    FCF Positive and Growing$139.9M
    ✗LynchPositive and growing
    Operating Cash Flow$153.8M
    ✓PiotroskiCFO > 0
    (CFO / Total Assets) vs ROACFO/Assets=8.91%, ROA=1.35%
    ✓PiotroskiCFO/Assets > ROA
    Price / (CFO / Shares)6.1x
    ✓Dreman< 8x
    P/E or FCF YieldP/E=40.0x, FCF Yield=14.8%
    ✓PabraiP/E < 15 or FCF Yield > 10%
    FCF Positive7/13 years FCF positive
    ✓MarksPositive FCF in majority of recent years
    (OCF - CapEx) / Market Cap14.8%
    ✓Ackman>= 4%
    Price / FCF per Share6.5x
    ✓Ackman<= 25
    Positive Operating Cash Flow frequency9/13 years positive
    ✗SleepPositive OCF in >= 70% of available years
    Operating Cash Flow - Capital Expenditures$139.9M
    ✓Neff> $0 (app proxy for a strong fundamental case)
    (Operating cash flow - capex) / market capitalization+14.17%; #447/4519 (top 9.9%)
    ✓OshaughnessyTop 10% of eligible cross-section
  • Valuation models60% pass✓ 3✗ 2▾

    Models split on RPD at $14.41 — fair values range $4.37–$49.38

    Graham fair value$4.37
    ✗Graham-229.7% margin vs $14.41
    Buffett fair value$11.03
    ✗Buffett-30.6% margin vs $14.41
    Munger fair value$40.62
    ✓Munger+64.5% margin vs $14.41
    Pabrai fair value$14.77
    ✓Pabrai+2.4% margin vs $14.41
    Ackman fair value$49.38
    ✓Ackman+70.8% margin vs $14.41

Where It Falls Short

  • Efficiency0% pass✓ 1✗ 10▾

    No clean pass — all 8 investors flag at least one efficiency criterion

    Current Ratio0.83
    ✗Graham>= 2.0
    ROIC (3-5 yr avg)-8.3%
    ✗Buffett> 10%
    ROIC - WACC-18.3%
    ✗BuffettPositive (WACC = 10%)
    EBIT / (NWC + Net Fixed Assets)N/A (invested capital <= 0)
    ✗Greenblatt> 25%
    Current Ratio Change YoY1.25 -> 1.28
    ✓PiotroskiIncreased YoY
    Revenue / Total Assets Change YoY0.51x -> 0.50x
    ✗PiotroskiImproved YoY
    Current Assets / Current Liabilities0.83
    ✗Dreman> 1.5
    Return on Invested Capital1.0%
    ✗Munger> 15%
    ROIC (high and growing)FY2023: ROIC=-8.2%; FY2024: ROIC=2.9%; FY2025: ROIC=0.9%
    ✗AkreLatest 3 consecutive FYs: ROIC > 15% in each
    Reinvestment Rate x ROIC0.9% (RR=100% x ROIC=0.9%)
    ✗AkreReinvestment Rate * ROIC > 10%
    ROIC (5-year)0/5 years above 12% (latest 0.9%)
    ✗SleepROIC > 12% in a majority of years
  • Profitability6% pass✓ 7✗ 28▾

    15 of 16 flag RPD's profitability — Graham, Buffett, Lynch +12 more

    Positive EPS (10 years)2/14 years positive
    ✗GrahamPositive EPS every year for 10 years
    EPS Growth (3-yr avg, 10-yr window)N/A (negative base EPS)
    ✗Graham>= 33% growth
    Net Income Positive (10+ years)2/14 years positive
    ✗BuffettPositive every year for 10+ years
    ROE (up to 5-year arithmetic mean)-21.5%
    ✗Buffett> 15% arithmetic mean (app rule)
    Operating Margin (10-yr trend)1.3% (latest)
    ✓BuffettStable or rising over 10 years
    Free Cash Flow Proxy$61.2M
    ✓BuffettPositive and growing
    Earnings Variance (10-yr CoV)N/A (negative mean EPS)
    ✗BuffettCoV < 0.3
    Retained Earnings Effectiveness
    ✗Buffett$1 retained -> > $1 market value created
    Basic earnings-growth PEG (dividends excluded)P/E 40.0x (growth N/A)
    ✗Lynch< 1.0 (ideally < 0.5)
    3-5 Year EPS CAGR
    ✗Lynch15-30% (Fast Grower); > 0% to pass
    ROE6.3%
    ✗Lynch> 15%
    EBIT / Enterprise Value0.7%
    ✗Greenblatt> 10%
    Earnings Yield + ROC AssessmentEY=0.7%, ROC=N/A (invested capital <= 0)
    ✗GreenblattBoth EY > 10% and ROC > 25%
    Net Income / Total Assets1.35%
    ✓PiotroskiROA > 0
    ROA Change YoY1.55% -> 1.35% (delta: -0.19%)
    ✗PiotroskiCurrent ROA > Prior ROA
    (CFO / Total Assets) vs ROACFO/Assets=8.91%, ROA=1.35%
    ✓PiotroskiCFO/Assets > ROA
    Gross Margin Change YoY70.3% -> 70.3%
    ✓PiotroskiImproved YoY
    Pre-Tax Income / Revenue2.4%
    ✗Dreman>= 8%
    Net Income / Shareholders' Equity6.3%
    ✗Dreman> 12%
    Margin of SafetyP/E=40.0x, P/B=6.1x
    ✗PabraiP/B < 1.5 or P/E < 15
    Return on Equity7.0% (3-yr avg)
    ✗AkreROE > 20% (3-year avg)
    Discount to Intrinsic ValueN/A (negative normalized EPS)
    ✗Marks>= 20% below intrinsic value
    Positive Net Income Frequency2/13 years positive
    ✗MarksPositive net income in >= 7 of last 10 years
    Operating Income / Revenue1.6%
    ✗Ackman>= 15%
    Net Income / Shareholders Equity6.3%
    ✗Ackman>= 15%
    5-Year EPS CAGR
    ✗Templeton> 0% (5-year EPS CAGR)
    Operating Margin Trend-10.8% (2023) -> 1.3% (2025)
    ✓TempletonNon-negative operating-margin trend over 3 years
    Revenue growth vs. gross and operating margin trendgross margin 70.2% -> 70.3%, operating margin -10.8% -> 1.3%
    ✓SleepRevenue rising; gross margin flat or falling; operating margin holding
    Net income / market capitalization+1.40%; #2878/6340 (top 45.4%)
    ✗AsnessTop 30% of eligible cross-section✗OshaughnessyTop 10% of eligible cross-section
    Gross profit / total assets+33.87%; #1226/3702 (top 33.1%)
    ✗AsnessTop 30% of eligible cross-section
    Net income / positive book equity+6.27%; #2305/5226 (top 44.1%)
    ✗AsnessTop 30% of eligible cross-section
    Negative 5-year standard deviation of ROA-0.0575; #2753/5884 (top 46.8%)
    ✗AsnessTop 30% of eligible cross-section
    3-5 Year Diluted EPS CAGR
    ✗Neff7%-20% annualized
    Positive Diluted-EPS Years2/10 years positive
    ✗Schloss>= 70% positive over 5-10 observed years (app rule)
  • Debt & Leverage8% pass✓ 1✗ 14▾

    11 of 12 flag RPD's debt & leverage — Graham, Buffett, Lynch +8 more

    LT Debt vs Net Current Assets
    ✗GrahamLT Debt <= Net Current Assets
    Debt/Equity & Interest CoverageD/E: 4.06, IC: 1.3x
    ✗BuffettD/E < 0.5 AND Interest Coverage > 5x
    Total Debt / Equity4.06
    ✗Lynch< 0.33
    Cash - Long-term Debt
    ✗LynchPositive preferred
    LT Debt / Total Assets Change0.00% -> 0.00%
    ✓PiotroskiDecreased YoY
    Current Assets / Current Liabilities0.83
    ✗Dreman> 1.5✗SchlossCurrent ratio >= 1.50x (app cutoff)
    Total Debt / Shareholders' Equity4.06
    ✗Dreman< 0.8✗Templeton< 1.0 (fixed cap; proxy for below-sector-median leverage)✗SchlossD/E < 1.00x
    Debt Levels4.06
    ✗MungerDebt/Equity < 0.5✗AkreDebt/Equity < 0.3
    Interest Coverage & Debt/EBITDAIC=1.3x, D/EBITDA=15.5x
    ✗MarksInterest Coverage > 3x; Debt/EBITDA < 4x
    Total Debt / Shareholders Equity4.06
    ✗Ackman<= 1.0
    Negative debt-to-equity (higher means less debt)-4.0555; #4038/4210 (top 95.9%)
    ✗AsnessTop 30% of eligible cross-section
  • Growth13% pass✓ 5✗ 8▾

    7 of 8 flag RPD's growth — Graham, Lynch, Dreman +4 more

    EPS Growth (3-yr avg, 10-yr window)N/A (negative base EPS)
    ✗Graham>= 33% growth
    Basic earnings-growth PEG (dividends excluded)P/E 40.0x (growth N/A)
    ✗Lynch< 1.0 (ideally < 0.5)
    3-5 Year EPS CAGR
    ✗Lynch15-30% (Fast Grower); > 0% to pass
    Inventory Growth vs Revenue GrowthN/A (no inventory)
    ✓LynchInventory growth < Revenue growth
    EPS Growth Direction$-4.18 (2013) -> $0.36 (2025)
    ✓DremanPositive over recent years
    EPS CAGR
    ✗Dreman> 5% annualized
    Positive Net Income Frequency2/13 years positive
    ✗MarksPositive net income in >= 7 of last 10 years
    3yr Median Revenue Growth8.5%
    ✓Ackman>= 5%
    Positive EPS Growth Frequency2/5 years with positive EPS growth
    ✗AckmanPositive EPS growth in >= 3 of last 5 years
    5-Year EPS CAGR
    ✗Templeton> 0% (5-year EPS CAGR)
    Revenue growth vs. gross and operating margin trendgross margin 70.2% -> 70.3%, operating margin -10.8% -> 1.3%
    ✓SleepRevenue rising; gross margin flat or falling; operating margin holding
    5-year Revenue CAGR15.9%
    ✓SleepCAGR > 7%
    3-5 Year Diluted EPS CAGR
    ✗Neff7%-20% annualized
  • Verdicts14% pass✓ 2✗ 12▾

    Split decision: 12 FAIL · 2 NEUTRAL · 2 PASS

    Overall verdict
    ✗GrahamFAIL (1/9)✗BuffettFAIL (2/9)✗LynchFAIL (1/7)•GreenblattNot ranked•PiotroskiNEUTRAL (F-Score 6)✗DremanFAIL (2/11)✗MungerFAIL (1/4)✗PabraiFAIL (1/3)✗AkreFAIL (1/6)✗MarksFAIL (1/5)✓AckmanPASS (4/9)✗TempletonFAIL (2/8)✓SleepPASS (3/6)✗AsnessFAIL (Rank #1659/2370 (Top 70.0%))✗NeffFAIL (2/6)✗SchlossFAIL (1/7)•OshaughnessyNEUTRAL (Not ranked)
  • Valuation23% pass✓ 7✗ 21▾

    10 of 13 flag RPD's valuation — Graham, Lynch, Greenblatt +7 more

    Price / 3-yr avg EPS
    ✗Graham<= 15x
    Price-to-Book Ratio6.1x
    ✗Graham<= 1.5x
    P/E x P/B
    ✗Graham<= 22.5
    Basic earnings-growth PEG (dividends excluded)P/E 40.0x (growth N/A)
    ✗Lynch< 1.0 (ideally < 0.5)
    EBIT / Enterprise Value0.7%
    ✗Greenblatt> 10%
    Earnings Yield + ROC AssessmentEY=0.7%, ROC=N/A (invested capital <= 0)
    ✗GreenblattBoth EY > 10% and ROC > 25%
    Price / EPS40.0x
    ✗Dreman< 12x✗Templeton< 12x (fixed ceiling; proxy for the market's cheapest 40%)
    Price / (CFO / Shares)6.1x
    ✓Dreman< 8x
    Price / Book Value per Share6.1x
    ✗Dreman< 1.2x✗Templeton< 1.5x✗SchlossP/B <= 0.80x (app cutoff)
    Valuation ReasonablenessP/E=40.0x, OE Yield=6.5%
    ✓MungerP/E < 25 or Owner Earnings Yield > 5%
    P/E or FCF YieldP/E=40.0x, FCF Yield=14.8%
    ✓PabraiP/E < 15 or FCF Yield > 10%
    P/B or P/E vs. Historical AverageP/E=40.0x, P/B=6.1x
    ✗MarksP/E < 15 or P/B < 2.0
    Discount to Intrinsic ValueN/A (negative normalized EPS)
    ✗Marks>= 20% below intrinsic value
    Price / FCF per Share6.5x
    ✓Ackman<= 25
    Price vs. Trailing Low284% of trailing low ($5.07)
    ✗Templeton<= 120% of trailing low (certified split-adjusted live window)
    Net income / market capitalization+1.40%; #2878/6340 (top 45.4%)
    ✗AsnessTop 30% of eligible cross-section✗OshaughnessyTop 10% of eligible cross-section
    Positive book equity / market capitalization+0.2235; #4075/6449 (top 63.2%)
    ✗AsnessTop 30% of eligible cross-section
    Price / Diluted EPS40.0x
    ✗NeffP/E <= 15x (app proxy for a P/E 40%-60% below the market)
    (EPS CAGR % + Dividend Yield %) / P/E
    ✗Neff> 0.7 (Neff's published traditional edge)
    Price / Tangible Book Value per ShareN/A (non-positive TBVPS)
    ✗SchlossP/TBV <= 1.00x (app cutoff)
    Book Value per Share Change+72.2%
    ✓SchlossLatest BVPS >= earliest BVPS over >= 3 years (app rule)
    Revenue / market capitalization+0.8610; #1948/5247 (top 37.1%)
    ✗OshaughnessyTop 10% of eligible cross-section
    (Operating cash flow - capex) / market capitalization+14.17%; #447/4519 (top 9.9%)
    ✓OshaughnessyTop 10% of eligible cross-section
    Trailing six-month price return through the evaluation date+184.22%; #164/6202 (top 2.6%)
    ✓OshaughnessyTop 10% of eligible cross-section

Business & financials

Financial snapshot: annual FY 2025. Current investor scores may use newer quarterly data.

Company Profile

Industry: Business Services
Size: Small Cap($987.6M)
Revenue: $859.8M+1.9% YoY
Net Income: $23.4M-8.4% YoY

Financial Snapshot

Operating Margin1.3%
Return on Equity15.1%
Debt / Equity5.77
Current Ratio1.28
EPS (Diluted)$0.36−10.0% 1y
Shares Retired−3.4% / −6.5% 2y

Shareholder Return

Fiscal 2025

Issued 3.4% of shares last year, 6.5% issued over two.

Buybacks
—
Dividends
—

What drove EPS

A buyback raises earnings per share without the company earning more. This splits each year's change into the two.

FY25
−10.0% = −8.4% + −1.7%
Earnings Fewer shares More shares

Share count is the denominator the filer used for diluted EPS, recovered as net income ÷ EPS — not the balance-sheet count, which is a point-in-time figure and would put the timing difference into this split. Years with a loss are omitted: a smaller share count makes a loss per share larger, so the decomposition inverts.

Company Financials

Latest TTM and quarters alongside annual years

TTM sums four consecutive quarters and uses the latest quarter-end balances. Quarter columns show three-month results; annual columns show full-year totals. Growth compares the same period a year earlier. EPS is not added for TTM; full-year ratios are blank for quarters.

The latest annual period end is unavailable. Showing the latest fiscal cycle’s quarters; quarter and annual columns may overlap. Quarterly shows the full quarter history.

MetricTTM · 2026-09-30

2025-10-01 – 2026-09-30

Sources · derived quarter values

Derived from cumulative filings: revenue, net income, operating income, gross profit, ebit, pre tax income, interest expense, operating cash flow, depreciation amortization, capex.

Q3 FY 2026

2026-07-01 – 2026-09-30

Sources · derived quarter values

Derived from cumulative filings: operating cash flow, depreciation amortization, capex.

Q2 FY 2026

2026-04-01 – 2026-06-30

Sources · derived quarter values

Derived from cumulative filings: operating cash flow, depreciation amortization, capex.

Q1 FY 2026

2026-01-01 – 2026-03-31

Sources
FY 2025
Sources
  • 10-K · 2026-02-19
FY 2024
Sources
  • 10-K · 2025-02-28
FY 2023
Sources
  • 10-K · 2024-02-26
FY 2022
Sources
  • 10-K · 2023-02-24
FY 2021
Sources
  • 10-K · 2022-02-24
Market Cap$987.6Mcurrent------$781.8Mest.$2.4Best.$3.4Best.$2.4Best.$5.6Best.
Revenue$850.4M↓1%$212.4M↓3%$210.9M↓2%$209.7M$859.8M↑2%$844.0M↑9%$777.7M↑14%$685.1M↑28%$535.4M
Operating Income$13.7M↑6%$8.9M↑52%$3.0M↓14%-$558.0K↓452%$11.6M↓67%$35.0M↑142%-$84.3M↑24%-$111.6M↑7%-$120.1M
Net Income$13.8M↓38%$3.5M↓64%$6.1M↓27%$1.1M↓46%$23.4M↓8%$25.5M↑117%-$152.8M↓23%-$124.7M↑15%-$146.3M
EPS (Diluted)--$0.05↓67%$0.09↓31%$0.02↓33%$0.36↓10%$0.40↑116%$-2.46↓15%$-2.13↑20%$-2.65
Gross Margin69.1%↓2%69.6%↓1%68.9%↓2%69.1%↓4%70.3%70.3%70.2%↑2%68.7%68.4%
Operating Margin1.6%↑7%4.2%↑56%1.4%↓12%-0.3%↓454%1.3%↓68%4.2%↑138%-10.8%↑33%-16.3%↑27%-22.4%
ROE6.3%↓64%———15.1%↓90%144.1%↑11%129.3%↑24%103.9%↓11%116.1%
Total Debt$895.2M$895.2M$894.2M$893.2M↓4%$892.3M↓4%$934.3M$930.0M↑14%$815.9M$812.1M
Shareholders' Equity$220.7M↑74%$220.7M↑74%$196.7M↑117%$174.8M↑231%$154.7M↑774%$17.7M↑115%-$118.2M↑2%-$120.1M↑5%-$126.0M
Current Ratio0.83↓30%0.83↓30%0.80↓41%0.78↓37%1.28↑3%1.25↑12%1.11↑16%0.96↑4%0.92
Debt / Equity4.06↓42%4.06↓42%4.55↓54%5.11↓71%5.77↓89%52.75↑770%-7.87↓16%-6.80↓5%-6.45
Operating Cash Flow$144.5M↓20%$30.1M↓23%$37.0M↓22%$39.8M↑34%$153.8M↓10%$171.7M↑65%$104.3M↑33%$78.2M↑45%$53.9M
Free Cash Flow$139.9M↓19%$29.9M↓14%$35.8M↓23%$37.7M↑33%$146.2M↓13%$168.2M↑68%$99.9M↑73%$57.8M↑29%$44.9M

Score history

Historical Score Timeline

Industry peers

Industry Peers

Similar companies in Business Services

RPD vs Peers — Financial Grading

Revenue$859.8MBottom 25%
Net Income$23.4MMedian
ROE15.1%Median
D/E5.77Bottom 25%
Op. Margin1.3%Bottom 25%
Curr. Ratio1.28Median
CompanyMarket CapPriceRevenueNet IncomeROED/EOp. MarginCurr. RatioGrahamBuffettLynchGreenblattPiotroskiDreman
AUTOMATIC DATA PROCESSING INCADP$122.3B$309.93$21.9B$4.4B73.2%0.8224.2%1.054/95/93/70/3F-Score 65/11
ELECTRONIC ARTS INC.EA$52.9B$209.70$7.5B$887.0M13.1%0.2215.4%1.051/94/94/70/3F-Score 66/11
Rubrik, Inc.RBRK$22.6B$109.88$1.3B$348.8M67.1%—-26.2%1.691/90/92/70/3F-Score 62/11
AECOMACM$9.1B$70.50$16.1B$561.8M22.5%1.096.4%1.141/93/93/71/3F-Score 82/11
COMMVAULT SYSTEMS INCCVLT$6.2B$152.07$1.2B$70.7M942.8%—6.3%1.951/92/94/70/3F-Score 66/11
WPP plcWPP$6.0B$27.79$18.2B$289.5M-8.5%1.942.8%0.891/92/91/70/3F-Score 32/11
VARONIS SYSTEMS INCVRNS$5.6B$48.94$623.5M$129.3M-21.6%0.76-23.5%1.971/90/91/70/3F-Score 51/11
ROBERT HALF INC.RHI$4.3B$42.00$5.4B$133.0M10.4%—1.4%1.532/95/91/70/3F-Score 52/11